LeonaBio, Inc. (LONA)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
LONA price, last 12 months
Key stats
- Previous close
- $4.99
- Open
- $5.59
- Day range
- $3.12 – $5.79
- 52-week range
- $3.12 – $14.21
- Volume
- 340.3K
- Avg volume (20 days)
- 69.7K
- Market cap
- $55.5M
Performance
Technicals and fundamentals
About LeonaBio, Inc.
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $55.5M